08:38 ETWorld's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceuticalprnewswire·Apr 28 at 07:39 AM浙江博锐生物制药股份有限公司科兴生物制药股份有限公司
UBS lowers the target price for SINO BIOPHARM to 11 yuan, rating it as "Buy"AASTOCKS·Mar 29 at 11:28 PM516930-1.81%159892-0.41%
